LIC
Listing performance
Scheduled dates
Tentative timetable — a past date is not confirmation the step completed
Issue details
- IPO date
- 04 May 2022 – 09 May 2022
- Listing date
- 17 May 2022
- Face value
- ₹10 per share
- Issue price
- ₹949 per share
- Lot size
- 15 shares
- Total issue size
- ₹20,557 Cr
- Market cap at offer price
- ₹6,00,242 Cr
- Promoter holding
- 100.00% → 96.50% pre-issue → post-issue
- ISIN
- INE0J1Y01017
- Registrar
- Kfin Technologies Ltd.
- Lead managers
- Axis Capital Ltd.
- Registered office
- Yogakshema, Jeevan Bima Marg, Nariman Point, Maharashtra
Reservation and application size
How the issue is split between investor categories, and what each may bid
| Investor category | Shares | % of net | % of total |
|---|---|---|---|
| Anchor investor · within QIB | 5,92,96,853 | — | — |
| Market maker | 0 | — | — |
Application size
Minimum 15 shares per lot, in multiples, at ₹949
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 15 | ₹14,235 |
| Retail (max) | 14 | 210 | ₹1,99,290 |
| S-HNI (min) | 15 | 225 | ₹2,13,525 |
| S-HNI (max) | 70 | 1,050 | ₹9,96,450 |
| B-HNI (min) | 71 | 1,065 | ₹10,10,685 |
Category limits
| Category | Bid size | Cut-off |
|---|---|---|
| Retail (RII) | Up to ₹2 lakh | Yes |
| Small HNI (sNII) | ₹2 lakh – ₹10 lakh | No |
| Big HNI (bNII) | Above ₹10 lakh | No |
| Employee | Up to ₹5 lakh | Yes |
Bidding at cut-off means accepting the final issue price without naming one. Only retail and employee applicants may do so.
Anchor investors
Institutional allocation placed a day before the issue opens, carved out of the QIB portion and locked in after listing.
Valuation and performance
Valuation at offer price
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS (₹) | 4.70 | — |
| P/E (×) | 201.91 | — |
| Market cap | — | ₹6,00,242 Cr |
Key performance indicators
- Return on net worth
- 45.65%
- NAV per share
- ₹10.30
Single period as reported. Year-on-year movement is in the financials table below, where every period is published.
About LIC
Life Insurance Corporation of India (LIC) was established on September 1, 1956 under the Life Insurance Corporation Act, 1956. It is the largest life insurer in India with a 61.6% market share in terms of premiums (GWP) and 61.4% market share in terms of New Business Premium as of December 31, 2021. The Corporation provides life insurance products across individual, group, and pension segments through its network of individual agents, corporate agents, and other distribution channels. It operates both in India and select international markets through subsidiaries. The Corporation generates revenue primarily from premiums collected on life insurance policies, with renewal premiums forming a significant portion of total revenue.
Company Analysis
from RHPLife Insurance Corporation of India is India's largest life insurer providing life insurance products and services in India and select international markets, operating across individual, group, and pension business segments.
Life Insurance Corporation of India (LIC) was established on September 1, 1956 under the Life Insurance Corporation Act, 1956. It is the largest life insurer in India with a 61.6% market share in terms of premiums (GWP) and 61.4% market share in terms of New Business Premium as of December 31, 2021. The Corporation provides life insurance products across individual, group, and pension segments through its network of individual agents, corporate agents, and other distribution channels. It operates both in India and select international markets through subsidiaries. The Corporation generates revenue primarily from premiums collected on life insurance policies, with renewal premiums forming a significant portion of total revenue.
Objects of the Issue
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges and carry out Offer for Sale ₹205,572.31 million p.17
- Not specified in this document section
- Achieve the benefits of listing the Equity Shares on the Stock Exchanges and enhance visibility and brand image as well as provide a public market for the Equity Shares in India p.104
- Offer for Sale by the Selling Shareholder (President of India, acting through the Ministry of Finance, Government of India) ₹205,572.31 million (subject to finalisation of Basis of Allotment) p.569
Issue Structure
- Total Issue
- ₹205,572.31 million (221,374,920 Equity Shares)
- Fresh Issue
- 0 (Offer for Sale only, no fresh issue)
- Offer for Sale
- 221,374,920 Equity Shares aggregating to ₹205,572.31 million
- Price Band
- ₹902 per Equity Share (Floor Price) to ₹949 per Equity Share (Cap Price)
- Lot Size
- 15 Equity Shares and in multiples of 15 Equity Shares thereafter
- Face Value
- ₹10 per Equity Share
Business Model
The Corporation earns revenue primarily through collection of premiums on individual and group life insurance policies. For Fiscal 2021 and the nine months ended December 31, 2021, renewal premiums were ₹2,203,275.87 million and ₹1,589,522.50 million respectively, constituting 54.29% and 55.63% of total premium. Individual agents procured 96.20% of individual new business premium during the nine months ended December 31, 2021. Revenue also comes from investment returns on policy funds. The Corporation segregated its single consolidated 'Life Fund' into participating policyholders' fund and non-participating policyholders' fund effective September 30, 2021.
Business Segments
SWOT Analysis
- • Largest life insurer in India with dominant market position(p.17)
- • Most productive agent network in Indian life insurance sector(p.35)
- • Largest individual agent network with scale advantage(p.35)
- • Established market presence for over 65 years(p.17)
- • Largest life insurance company by market share in India(p.47)
- • Strong premium growth and asset base(p.52)
- • High claims settlement ratio demonstrating operational efficiency(p.38)
- • Diversified product portfolio with strong participation products(p.43)
- • Fifth largest life insurer globally by GWP with dominant position in fast-growing Indian market(p.107)
- • Largest asset manager in India with established financial performance track record(p.107)
- • Highest RoNW among listed peers in India(p.107)
- • Unparalleled agency force across omni-channel distribution network(p.107)
- • Dominant market share of 61.4% in new business premium as of December 2021(p.124)
- • Trusted brand and customer-centric business model(p.107)
- • Dominant market position with unparalleled gap versus competitors(p.142)
- • Largest agent network providing unmatched distribution reach(p.139)
- • Strong brand trust built over 65+ years(p.139)
- • Largest asset manager in India with superior investment management(p.176)
- • Non-linked product portfolio provides resilience to market volatility(p.165)
- • Superior operating efficiency with lower cost structure(p.148)
- • Agent productivity highest among peers by premiums and policies(p.172)
- • Fifth largest life insurer globally with strong international presence(p.142)
- • Largest agent network in India with exceptional productivity and scale(p.192)
- • Most productive agent network by new business per agent and policies sold(p.192)
- • Dominant market share in participating products providing structural advantages(p.191)
- • Largest asset manager in India with substantial scale advantage(p.194)
- • Significantly lower operating expense ratio than private competitors(p.194)
- • Extensive omni-channel distribution network covering urban and rural India(p.192)
- • Market leadership in health insurance and annuity products among life insurers(p.191)
- • Proven track record of strong financial performance and profitability(p.194)
- • Established brand with 65+ years of market presence and sovereign guarantee(p.244)
- • Strong solvency position maintained above regulatory minimum(p.242)
- • Conservative debt portfolio with 95.90% in sovereign and AAA rated securities(p.237)
- • Diversified reinsurance partnerships with highly-rated counterparties(p.243)
- • Comprehensive three-line risk management framework in place(p.238)
- • Designated as Domestic Systemically Important Insurer (D-SII)(p.277)
- • Established subsidiary operations across multiple geographies(p.277)
- • Significant financial presence through associates including major banking interest(p.281)
- • Long operational history with early technology adoption(p.277)
- • Multiple major awards and recognitions for excellence(p.277)
- • Strong corporate governance recognition(p.278)
- • Diversified life insurance business with individual and group products across multiple segments(p.348)
- • Significant consolidated net block of fixed assets demonstrating infrastructure capability(p.342)
- • Substantial investment portfolio with diversified asset classes(p.393)
- • Strong cash and bank balances providing liquidity(p.343)
- • Dominant market position with 61.6% premium market share(p.456)
- • Largest asset manager in India with ₹40.1 trillion AUM(p.457)
- • Largest individual agent network with 1.33 million agents(p.457)
- • Broad geographic coverage with 2,048 branch and 1,559 satellite offices(p.457)
- • Strong brand recognition as third strongest global insurance brand(p.457)
- • Diversified product portfolio with 32 individual and 11 group products(p.457)
- • Profitable operations with ₹29,741.39 million net profit for Fiscal 2021(p.457)
- • Diversified investment portfolio with significant government securities holdings(p.464)
- • Improved persistency ratios indicating better business quality(p.469)
- • Strong solvency position exceeding regulatory requirements(p.471)
- • Substantial AUM growth trajectory(p.468)
- • Healthy net premium growth over multiple years(p.468)
- • Large premium non-par pension and annuity business generating significant surpluses(p.514)
- • Substantial and growing investment income across business segments(p.514)
- • Significant operating cash flows demonstrating strong premium collection capacity(p.517)
- • Extensive branch and office network supporting customer reach(p.535)
- • High attrition among individual agents(p.35)
- • Regulatory non-compliance with investment transfer requirements(p.33)
- • Significant loss exposure from non-compliant investments(p.33)
- • Dependence on individual agents for majority of new business premium(p.35)
- • Deterioration in persistency metrics post-pandemic(p.32)
- • Continued regulatory compliance challenges with deadline approaching(p.33)
- • Declining market share to private insurers(p.47)
- • High concentration of individual premiums in five states(p.55)
- • Regulatory breach related to mutual fund asset management shareholding(p.46)
- • Significant outstanding litigation across multiple jurisdictions(p.44)
- • Terminal bonus accounting creating future solvency pressure(p.49)
- • High fraud incidents involving internal and external parties(p.41)
- • Dependence on key managerial personnel with high attrition in actuarial staff(p.56)
- • Exposure to high concentration in individual participating product portfolio(p.107)
- • Exchange rate risk affecting value of equity shares for foreign investors(p.74)
- • Bidders limited ability to withdraw bids after submission, exposing them to market risk(p.74)
- • Persistency ratios lower than private sector peers(p.175)
- • Lower average premium per policy reflects smaller ticket sizes(p.172)
- • Higher reinsurance ceding costs compared to industry(p.151)
- • Exposed to longevity risk and mortality-linked financial impact(p.156)
- • Heavy dependence on participating products creating concentration risk(p.191)
- • Lower average policy ticket size creates higher processing costs and volume dependency(p.195)
- • Declining persistency ratios indicating policy lapse challenges(p.225)
- • Relatively small presence in unit-linked products despite growth(p.196)
- • Active agent count declining due to COVID-19 pandemic impact(p.212)
- • Duration mismatch between assets and liabilities due to regulatory constraints(p.240)
- • Exposure to mortality and morbidity risk if actual experience deviates from assumptions(p.240)
- • Expense management constraints with regulatory limits on management expenses(p.262)
- • Bifurcation of policyholders' fund created complexities and solvency concerns(p.315)
- • Significant long-term pension obligation liability requiring five-year amortization(p.315)
- • Regulatory compliance breach in mutual funds shareholding(p.283)
- • Potential regulatory requirement to exit housing finance through associates(p.284)
- • Significant contingent liabilities from tax disputes and legal matters(p.371)
- • Large portfolio of non-performing investments requiring provisions(p.393)
- • Significant unclaimed amounts and liabilities to policyholders(p.345)
- • Complex organizational structure with multiple subsidiaries and associates requiring consolidation adjustments(p.349)
- • Heavy dependence on individual agent channel for premium sourcing(p.457)
- • Decline in active individual agents due to COVID-19 impact(p.459)
- • Regulatory non-compliance regarding pension and group annuity fund investments(p.460)
- • Large exposure to non-performing assets in downgraded securities(p.460)
- • Decreased persistency ratios during COVID-19 period(p.459)
- • Reduced agent productivity due to pandemic impact(p.459)
- • High operating expense ratio relative to premiums(p.469)
- • Significant employee pension liability burden(p.465)
- • Absence of interest rate hedging arrangements(p.464)
- • Duration mismatch between assets and liabilities(p.464)
- • Limited long-term fixed income product availability in capital markets(p.464)
- • Significant exposure to contingent tax liabilities from multiple contested tax assessments(p.519)
- • Large volume of pending litigation (approximately 27,214 cases) creating management and financial uncertainty(p.521)
- • High volume of consumer complaints, particularly regarding claim settlement delays and repudiation(p.521)
- • Exposure to constitutional challenges threatening the IPO and amended governance structure(p.523)
- • Dependence on government shareholding with statutory prohibition limiting private ownership(p.565)
- • Dependence on internal data and system limitations(p.634)
- • Ongoing COVID-19 impact uncertainty not reflected in mortality assumptions(p.634)
- • High operational risk capital requirement(p.630)
- • Material persistency and mass-lapse risk exposure(p.630)
- • Indian life insurance industry projected to grow at 14-15% CAGR(p.17)
- • Strong historical industry growth trajectory(p.17)
- • Sole public sector player in 24-player competitive market(p.17)
- • Expanding life insurance penetration in India(p.62)
- • Growing digital distribution channels(p.47)
- • Expansion into new asset classes(p.55)
- • Strong profitability from non-participating products(p.40)
- • Regulatory requirement for rural and social sector business(p.59)
- • Rising penetration in underpenetrated Indian life insurance market with growing financial awareness(p.119)
- • Expanding middle-income households expected to drive insurance demand substantially(p.118)
- • Digital transformation and technology adoption for wider market reach(p.122)
- • Rising household financial savings driving life insurance demand growth(p.120)
- • Favorable regulatory environment with increased FDI limits and structural reforms(p.131)
- • Massive untapped protection gap providing expansion potential(p.138)
- • Low insurance penetration and density versus developed markets(p.138)
- • Strong industry growth forecasts driven by multiple tailwinds(p.154)
- • Rising demand for protection and non-participating products(p.153)
- • Digital distribution channels and omni-channel strategy offering growth(p.155)
- • Rising elderly population driving pension fund demand(p.156)
- • Significant growth in life insurance industry expected over multi-year period(p.196)
- • Substantial opportunity in non-participating products, especially term and health insurance(p.192)
- • Growing elderly population driving demand for pension and annuity products(p.196)
- • Micro Insurance market with strong growth potential and low penetration(p.209)
- • Increased insurance awareness from COVID-19 pandemic driving demand(p.196)
- • Opportunity to increase bancassurance channel penetration with digital solutions(p.196)
- • Digital sales channel growing rapidly with significant untapped potential(p.197)
- • Significant penetration potential in rural and under-privileged segments(p.246)
- • Growing millennial segment demand for life insurance products(p.244)
- • Digital transformation and e-governance initiatives to expand reach(p.255)
- • Infrastructure and renewable energy investment opportunities(p.251)
- • Digital transformation initiatives and technology modernization(p.277)
- • Expansion through strategic subsidiaries in insurance business(p.280)
- • Diversified financial services through associated companies(p.282)
- • Established charitable foundation for social impact(p.277)
- • Growth through unit-linked and variable insurance products(p.348)
- • Expansion of rural insurance business segment(p.393)
- • Growth in social sector insurance segment(p.393)
- • Increase non-participating product contribution through diversification(p.461)
- • Capitalize on growing demand for health insurance products(p.457)
- • Expand through increased foreign investment limit in insurance sector(p.461)
- • Benefit from favorable Indian macroeconomic and demographic trends(p.458)
- • Expand international operations across multiple countries(p.457)
- • Leverage digital channels for product distribution and customer engagement(p.457)
- • Expansion of digital sales channels and operational efficiency improvements(p.465)
- • Enhancement of persistency through technology-driven initiatives(p.469)
- • Growth in individual new business sum assured through high-ticket policies(p.469)
- • Opportunity to address protection gap in existing customer base(p.469)
- • Substantial tax-driven insurance demand during fiscal year-end, indicating seasonal growth potential(p.517)
- • Expansion potential in linked business with growing investment income(p.516)
- • Expansion of group business and annuity products(p.631)
- • Open market option monetization for individual pension plans(p.631)
- • Revival and reinstatement of lapsed policies(p.631)
- • COVID-19 pandemic adversely affecting distribution and operations(p.29)
- • Decline in active agent numbers due to pandemic(p.29)
- • Regulatory restrictions on commission caps limiting competitive response(p.36)
- • Risk of adverse persistency and policy surrenders(p.31)
- • Increased mortality claims during COVID-19 pandemic(p.31)
- • Low interest rate environment impacting investment returns(p.29)
- • Reputational risk from industry-wide conduct issues(p.31)
- • Increasing competition from private insurers and foreign players(p.47)
- • Interest rate risk and declining investment yields(p.40)
- • Regulatory changes and increased capital requirements(p.48)
- • COVID-19 pandemic impact on mortality and operations(p.38)
- • Macroeconomic downturn in India(p.67)
- • Industry slowdown from regulatory changes(p.62)
- • Catastrophic events and pandemics(p.61)
- • Labour unrest and union agitation(p.58)
- • Foreign investment restrictions limiting capital raising(p.58)
- • Volatility in financial markets and equity performance impacting linked product returns(p.125)
- • Intense competition from private life insurers post-liberalization(p.124)
- • Regulatory caps on commission and expenses reducing profitability incentives(p.132)
- • COVID-19 pandemic disrupting operations and in-person interactions central to business model(p.126)
- • Heightened competitive pressure from private players gaining ground(p.137)
- • Equity market volatility impacts ULIP demand and profitability(p.157)
- • Regulatory changes to commission structure and product requirements(p.157)
- • Competition from alternative investment vehicles and mutual funds(p.157)
- • COVID-19 pandemic impact on operations and claims experience(p.151)
- • Low product persistency across industry reducing premium stability(p.157)
- • Climate and environmental risks creating longevity and claims uncertainties(p.158)
- • Intense competition from growing private life insurance companies(p.191)
- • Regulatory changes affecting product design and profitability, particularly ULIP taxation(p.196)
- • Interest rate risk from low interest rate environment reducing investment yields(p.195)
- • Geographic concentration risk with top 10 states representing significant portion of NBP(p.192)
- • Dependence on government approval for surplus distribution policy changes(p.198)
- • Pandemic-related disruptions affecting agent productivity and policy lapses(p.212)
- • Increased competition from new entrants following FDI cap increase to 74%(p.244)
- • Market risk from interest rate, exchange rate and equity price volatility(p.239)
- • Regulatory and compliance burden with complex IRDAI requirements(p.244)
- • COVID-19 pandemic impacts on operations, mortality and business continuity(p.256)
- • COVID-19 pandemic uncertainties affecting business and financial statements(p.315)
- • Dependency on government as sole promoter affecting governance and operational autonomy(p.309)
- • Concentration of policy liabilities requiring substantial reserves(p.323)
- • Exposure to foreign exchange rate fluctuations through international operations(p.316)
- • Regulatory changes affecting surplus distribution and policy liability valuation(p.375)
- • Exposure to interest rate and investment market risks affecting asset valuations(p.373)
- • Dependence on mortality and morbidity assumptions that may deviate from experience(p.373)
- • COVID-19 related mortality strain and actuarial valuation uncertainties(p.375)
- • COVID-19 pandemic continues to adversely affect death claims and mortality experience(p.459)
- • Downturn in Indian macroeconomic environment could reduce demand for insurance(p.458)
- • Increased competition from private insurers following regulatory liberalization(p.461)
- • Regulatory restrictions on investments limit diversification and returns(p.459)
- • Tax law changes on ULIPs reduce market attractiveness of these products(p.461)
- • Continued distribution challenges from pandemic-related lockdowns and restrictions(p.459)
- • Interest rate sensitivity impacting product profitability and guarantees(p.464)
- • Declining interest rates increasing guarantee liability costs(p.464)
- • Rising interest rates causing policyholder surrenders(p.464)
- • Equity market fluctuations impacting unit-linked and participating product sales(p.464)
- • Equity market declines reducing investment income and triggering surrenders(p.464)
- • Seasonal business volatility affecting first and second quarter results(p.467)
- • Regulatory scrutiny over mutual fund shareholding compliance requirements(p.523)
- • Litigation risk from creditor insolvency proceedings affecting investment returns(p.524)
- • Outstanding debenture defaults with major debtors creating credit risk exposure(p.524)
- • Prolonged COVID-19 economic and regulatory uncertainty(p.634)
- • Longevity risk from future mortality improvements(p.630)
- • Interest rate and investment market volatility(p.630)
- • Expense inflation and cost uncertainty(p.630)
- • Regulatory and taxation environment changes(p.643)
Promoters
| Name | Role | Pre-Issue | Post-Issue |
|---|---|---|---|
| President of India, acting through the Ministry of Finance, Government of India | Promoter/Selling Shareholder | 100.00% | 96.5% |
| Government of India | Promoter | 100% | 96.5% |
| President of India, acting through the Ministry of Finance, Government of India | Promoter | 100.00% | 100.00% |
| Government of India | Promoter | — | — |
| President of India (Ministry of Finance, Government of India) | Promoter | 100% | 96.5% |
| Government of India | Promoter/Shareholder | 100% | — |
| President of India, acting through the Ministry of Finance, Government of India | Promoter/Selling Shareholder | — | 51% (as per Life Insurance Corporation Act requirements) |
| Government of India | Selling Shareholder / Central Government | 100% | At least 51% |
| President of India, acting through the Ministry of Finance, Government of India | Selling Shareholder | — | 20% |
Leadership
Auto-extracted from the company's RHP using AI, with each fact linked to its source passage (hover any row to see the quote & page). Provided for research only, not investment advice — verify against the official RHP before relying on it.